Masimo ROA 2010-2025 | MASI

Current and historical return on assets (ROA) values for Masimo (MASI) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Masimo ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2025-03-31 $-0.50B $2.29B -18.16%
2024-12-31 $-0.31B $2.63B -10.55%
2024-09-30 $0.08B $3.09B 2.64%
2024-06-30 $0.08B $2.89B 2.69%
2024-03-31 $0.08B $2.96B 2.67%
2023-12-31 $0.08B $3.04B 2.70%
2023-09-30 $0.09B $3.00B 2.89%
2023-06-30 $0.12B $3.01B 3.74%
2023-03-31 $0.12B $3.12B 3.82%
2022-12-31 $0.14B $3.21B 5.17%
2022-09-30 $0.17B $3.06B 6.97%
2022-06-30 $0.19B $2.96B 8.96%
2022-03-31 $0.22B $1.91B 12.31%
2021-12-31 $0.23B $1.89B 13.21%
2021-09-30 $0.23B $1.77B 13.73%
2021-06-30 $0.22B $1.68B 13.30%
2021-03-31 $0.23B $1.60B 13.75%
2020-12-31 $0.24B $1.71B 14.69%
2020-09-30 $0.22B $1.71B 14.28%
2020-06-30 $0.22B $1.64B 15.26%
2020-03-31 $0.21B $1.48B 15.59%
2019-12-31 $0.20B $1.40B 15.32%
2019-09-30 $0.19B $1.31B 15.58%
2019-06-30 $0.20B $1.23B 17.00%
2019-03-31 $0.20B $1.18B 17.76%
2018-12-31 $0.19B $1.16B 18.44%
2018-09-30 $0.14B $1.10B 14.05%
2018-06-30 $0.12B $1.01B 12.53%
2018-03-31 $0.12B $0.95B 13.02%
2017-12-31 $0.13B $0.91B 13.95%
2017-09-30 $0.36B $0.91B 41.02%
2017-06-30 $0.35B $0.90B 43.41%
2017-03-31 $0.34B $0.88B 45.70%
2016-12-31 $0.31B $0.82B 46.50%
2016-09-30 $0.11B $0.64B 17.85%
2016-06-30 $0.10B $0.60B 16.81%
2016-03-31 $0.09B $0.62B 15.09%
2015-12-31 $0.08B $0.60B 14.19%
2015-09-30 $0.08B $0.58B 13.90%
2015-06-30 $0.08B $0.58B 13.48%
2015-03-31 $0.07B $0.58B 13.08%
2014-12-31 $0.07B $0.57B 14.21%
2014-09-30 $0.06B $0.53B 12.65%
2014-06-30 $0.06B $0.50B 13.59%
2014-03-31 $0.07B $0.46B 15.09%
2013-12-31 $0.06B $0.44B 14.04%
2013-09-30 $0.06B $0.43B 16.12%
2013-06-30 $0.06B $0.40B 15.80%
2013-03-31 $0.06B $0.39B 16.22%
2012-12-31 $0.06B $0.38B 16.30%
2012-09-30 $0.06B $0.41B 16.14%
2012-06-30 $0.06B $0.38B 16.79%
2012-03-31 $0.06B $0.38B 16.85%
2011-12-31 $0.06B $0.37B 18.03%
2011-09-30 $0.07B $0.37B 19.35%
2011-06-30 $0.07B $0.35B 20.35%
2011-03-31 $0.06B $0.33B 20.22%
2010-12-31 $0.07B $0.31B 23.76%
2010-09-30 $0.07B $0.33B 22.27%
2010-06-30 $0.07B $0.30B 21.18%
2010-03-31 $0.07B $0.29B 20.63%
2009-12-31 $0.05B $0.36B 16.15%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $9.086B $2.094B
Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation.
Stock Name Country Market Cap PE Ratio
Intuitive Surgical (ISRG) United States $195.148B 85.47
Thermo Fisher Scientific (TMO) United States $162.069B 19.60
Edwards Lifesciences (EW) United States $45.045B 29.53
IDEXX Laboratories (IDXX) United States $43.992B 50.56
Alcon (ALC) Switzerland $43.297B 29.26
DexCom (DXCM) United States $32.517B 50.26
IQVIA Holdings (IQV) United States $28.414B 15.91
Mettler-Toledo (MTD) United States $25.128B 29.88
STERIS (STE) Ireland $23.368B 25.74
Waters (WAT) United States $20.841B 29.41
SONOVA HOLDING (SONVY) Switzerland $17.678B 0.00
Hologic (HOLX) United States $14.436B 15.69
Sysmex ADR (SSMXY) Japan $10.859B 30.80
Penumbra (PEN) United States $9.723B 76.31
Globus Medical (GMED) United States $8.010B 19.09
Glaukos (GKOS) United States $5.914B 0.00
Teleflex (TFX) United States $5.298B 8.75
TransMedics (TMDX) United States $4.370B 94.99
Integer Holdings (ITGR) United States $4.222B 22.12
PROCEPT BioRobotics (PRCT) United States $3.205B 0.00
LivaNova (LIVN) United Kingdom $2.515B 14.98
Nihon Kohden (NHNKY) Japan $2.346B 26.90
Veracyte (VCYT) United States $2.154B 30.23
Elekta AB (EKTAY) Sweden $1.991B 17.90
Alphatec Holdings (ATEC) United States $1.606B 0.00
Artivion (AORT) United States $1.312B 122.88
Tandem Diabetes Care (TNDM) United States $1.118B 0.00
OPKO Health (OPK) United States $1.079B 0.00
Integra LifeSciences Holdings (IART) United States $1.048B 5.57
Pulse Biosciences (PLSE) United States $1.029B 0.00
SiBone (SIBN) United States $0.787B 0.00
IRadimed (IRMD) United States $0.786B 39.87
Beta Bionics (BBNX) United States $0.586B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.571B 8.88
Mesa Laboratories (MLAB) United States $0.564B 13.22
OrthoPediatrics (KIDS) United States $0.546B 0.00
RxSight (RXST) United States $0.530B 0.00
AxoGen (AXGN) United States $0.498B 0.00
Pacific Biosciences Of California (PACB) United States $0.480B 0.00
Semler Scientific (SMLR) United States $0.451B 12.00
Delcath Systems (DCTH) United States $0.442B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.436B 0.00
AngioDynamics (ANGO) United States $0.389B 0.00
Treace Medical Concepts (TMCI) United States $0.389B 0.00
NeuroPace (NPCE) United States $0.341B 0.00
ClearPoint Neuro (CLPT) United States $0.327B 0.00
Biosig Technologies (BSGM) United States $0.284B 0.00
Alpha Tau Medical (DRTS) Israel $0.269B 0.00
908 Devices (MASS) United States $0.238B 0.00
Tactile Systems Technology (TCMD) United States $0.236B 14.27
Neuronetics (STIM) United States $0.224B 0.00
Sight Sciences (SGHT) United States $0.218B 0.00
Inogen (INGN) United States $0.201B 0.00
CVRx (CVRX) United States $0.172B 0.00
Spectral Diagnostics (EDTXF) Canada $0.171B 0.00
Rapid Micro Biosystems (RPID) United States $0.159B 0.00
LENSAR (LNSR) United States $0.155B 0.00
Accuray (ARAY) United States $0.146B 0.00
Anteris Technologies Global (AVR) Australia $0.137B 0.00
Lucid Diagnostics (LUCD) United States $0.111B 0.00
Atossa Genetics (ATOS) United States $0.110B 0.00
Monogram Orthopaedics (MGRM) United States $0.104B 0.00
Microbot Medical (MBOT) United States $0.095B 0.00
Sensus Healthcare (SRTS) United States $0.077B 46.60
EnVVeno Medical (NVNO) United States $0.070B 0.00
InspireMD (NSPR) United States $0.069B 0.00
Spectral AI (MDAI) United States $0.068B 0.00
Hyperfine (HYPR) United States $0.062B 0.00
EDAP TMS S.A (EDAP) France $0.059B 0.00
Covalon Technologies (CVALF) Canada $0.052B 21.11
Vicarious Surgical (RBOT) United States $0.045B 0.00
Precision Optics (POCI) United States $0.037B 0.00
Envoy Medical (COCH) United States $0.033B 0.00
DarioHealth (DRIO) United States $0.031B 0.00
Baird Medical Investment Holdings (BDMD) $0.026B 0.00
Adagio Medical Holdings (ADGM) United States $0.024B 0.00
NexGel (NXGL) United States $0.020B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.015B 0.00
WORK Medical Technology Group (WOK) China $0.010B 0.00
PAVmed (PAVM) United States $0.010B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.008B 0.00
Ekso Bionics Holdings (EKSO) United States $0.008B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
ReShape Lifesciences (RSLS) United States $0.006B 0.00
Check-Cap (CHEK) Israel $0.004B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.001B 0.00
Helius Medical Technologies (HSDT) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $0.000B 16.07
Longview Acquisition II (LGV) United States $0.000B 0.00